3-methoxy-o-demethylencainide has been researched along with Arrhythmia in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carey, EL; Duff, HJ; Oates, JA; Primm, RK; Roden, DM; Wang, T; Wilkinson, GR; Woosley, RL | 1 |
Antonaccio, MJ; Verjee, S | 1 |
Roden, DM; Wilkinson, GR; Wood, AJ; Woosley, RL | 1 |
Harrison, DC; Kates, RE; Quart, BD | 1 |
Barbey, JT; Echt, DS; Roden, DM; Thompson, KA; Woosley, RL | 1 |
1 review(s) available for 3-methoxy-o-demethylencainide and Arrhythmia
Article | Year |
---|---|
Disposition kinetics of encainide and metabolites.
Topics: Anilides; Arrhythmias, Cardiac; Biological Availability; Biotransformation; Encainide; Female; Humans; Kidney Diseases; Kinetics; Liver; Liver Cirrhosis; Pregnancy | 1986 |
2 trial(s) available for 3-methoxy-o-demethylencainide and Arrhythmia
Article | Year |
---|---|
Dosing recommendations for encainide.
Topics: Anilides; Arrhythmias, Cardiac; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Encainide; Heart Ventricles; Humans; Kinetics; Random Allocation | 1986 |
Antiarrhythmic activity, electrocardiographic effects and pharmacokinetics of the encainide metabolites O-desmethyl encainide and 3-methoxy-O-desmethyl encainide in man.
Topics: Adult; Aged; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Encainide; Female; Humans; Male; Middle Aged | 1988 |
2 other study(ies) available for 3-methoxy-o-demethylencainide and Arrhythmia
Article | Year |
---|---|
Encainide and its metabolites. Comparative effects in man on ventricular arrhythmia and electrocardiographic intervals.
Topics: Aged; Anilides; Arrhythmias, Cardiac; Electrocardiography; Encainide; Female; Heart; Heart Ventricles; Humans; Kinetics; Male; Middle Aged; Regression Analysis | 1984 |
Relation of blood level and metabolites to the antiarrhythmic effectiveness of encainide.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Biotransformation; Circadian Rhythm; Dose-Response Relationship, Drug; Encainide; Heart Ventricles; Humans; Kinetics; Myocardial Contraction; Time Factors | 1986 |